The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure-Reference-Cited by-同舟云学术

The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure

Published:2023-09 Issue: Volume:132 Page:107349
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ratajczak Błażej,Przybyłowicz-Chalecka Anna,Czerwińska-Rybak Joanna,Kanduła Zuzanna,Ustaszewski Adam,Gil Lidia,Lewandowski Krzysztof,Jarmuż-Szymczak Małgorzata

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update;Molica;Expert Rev. Mol. Diagn.,2017

2. Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia;Bozkurt;Med Oncol.,2013

3. Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy;Chen;Leukemia,2017

4. Mitelman, F., Johansson, B., Mertens, F. Mitelman database of chromosome aberrations and gene fusions in cancer. https://mitelmandatabase.isb‐cgc.org (2022). Accessed 13 Dec 2021.

5. Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: the experience of the international registry for chronic myeloid leukemia in children and adolescents;Millot;Cancer,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco;Annals of Hematology;2024-04-24

2. Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation;Leukemia Research;2024-02